Back to today’s briefing

Story perspectives

Dianthus Surprises with Smaller Loss, Revenues Disappoint

3/13/2025

50 7

Summary

Story summary

Dianthus Therapeutics surprised investors with a quarterly loss of $0.81 per share, outperforming expectations of $0.85, though revenues of $1.33 million fell short by 5.36%. Meanwhile, Xilio Therapeutics reported a loss of $0.20 per share, surpassing forecasts, but its revenues of $1.72 million also disappointed. Voyager Therapeutics faced a significant miss with a loss of $0.59 per share.

1 of 1

Story summary

Dianthus Therapeutics surprised investors with a quarterly loss of $0.81 per share, outperforming expectations of $0.85, though revenues of $1.33 million fell short by 5.36%. Meanwhile, Xilio Therapeutics reported a loss of $0.20 per share, surpassing forecasts, but its revenues of $1.72 million also disappointed. Voyager Therapeutics faced a significant miss with a loss of $0.59 per share.